Via histopathology, of the tumor tissue samples obtained before and after anti-PD-1 treatment, increased expression of CD8+ PD-1 or PD-L1 at the invasive tumor margin correlated with response to anti-PD-1 treatment. The gene discussed is CD8A; the disease is neoplasm.